pharmaceuticals

The facility, named Modulus, can be adapted to manufacture up to four vaccines or biopharmaceuticals at the same time, and will be fully operational in mid-2026 and create 200 skilled jobs.

The purchase consideration for the proposed acquisition stands at RMB2,830,000, to be paid in two instalments.

Beyond the significant health implications, these innovations open substantial investment opportunities.

Vietnam has the highest level of overlap

As patents for innovator biologics have expired, biosimilars have emerged.

Big vaccine news makes little difference to pharma giant shares.

This three-times a week route will be the only non-stop air cargo link from the US Northeast to Singapore.

Things are looking up for Singapore’s trade sector, with NODX expanding 7.7% in August 2020.

“COVID-19 has created a challenging operating environment, however, we remain agile and to adapt to a different operating environment,” says Hyphens Pharma’s executive chairman & CEO Lim See Wah

iX Biopharma has entered into a 10-year licensing agreement with Yiling Pharmaceutical in China for the licensing, supply, and distribution of Wafesil, a fast-dissolving sublingual sildenafil wafer for the treatment of male erectile dysfunction.